{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:14:43Z","timestamp":1793499283724,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Neuroendocrine pituitary tumors (PitNETs) are classified based on clinical manifestation and expression of pituitary cell lineage-specific transcription factors (TFs) and hormones. A subtype of tumors in patients with acromegaly was found to express PIT-1 and SF-1 TFs, two markers of distinct pituitary cell lineages. These tumors have been described as multilineage or \u201csomatogonadotoph\u201d tumors. The aim of our study was to clarify their identity and cell type origin using extensive transcriptomic analysis. For this purpose, we analyzed the RNA sequencing (RNAseq) data from 546 PitNETs (including 193 tumors of patient with acromegaly) and single cell RNAseq data from somatotroph and gonadotroph tumors and normal pituitary tissue. Somatrotroph PitNETs co-expressing PIT-1 and SF-1 TFs were identified in each of the analyzed RNAseq dataset. Their transcriptomic profile and pituitary TF activity closely resembled those of other somatotroph tumors, while differing substantially from gonadotroph PitNETs, though they retained <jats:italic>NR5A1<\/jats:italic> (SF-1) activity and expressed some SF-1-regulated genes (e.g., <jats:italic>LHB<\/jats:italic> and <jats:italic>GNHRH<\/jats:italic>). Notably, SF-1 appeared to regulate a slightly different set of genes in double positive somatotroph PitNETs and gonadotroph tumors. Analysis of scRNAseq data revealed a subcluster of normal gonadotroph cells expressing <jats:italic>POU1F1<\/jats:italic> (PIT-1), but tumor cells from PIT-1\/SF-1 PitNETs did not resemble this normal gonadotroph cell subtype. Genes expression profiles of three subtypes of somatotroph tumors were distinguished through analyses of both bulk- and scRNAseq data. From transcriptomic perspective \u2014 based on gene co-regulation and pituitary TF activity \u2014 PitNETs of patients with acromegaly that co-express PIT-1 and SF-1 represent a subtype of PIT-1 lineage tumors, and the molecular data do not support classifying them as multilineage tumors.<\/jats:p>","DOI":"10.1186\/s40478-025-02091-z","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T11:49:00Z","timestamp":1755172140000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["PIT-1\/SF-1-positive pituitary tumors in patients with acromegaly: transcriptomic perspective"],"prefix":"10.1186","volume":"13","author":[{"given":"Julia","family":"Rymuza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Bujko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"key":"2091_CR1","volume-title":"Endocrine and neuroendocrine tumours","author":"WHO Classification of Tumours Editorial Board","year":"2022","unstructured":"WHO Classification of Tumours Editorial Board (2022) Endocrine and neuroendocrine tumours, 5th edn. International Agency for Research on Cancer, Lyon","edition":"5"},{"key":"2091_CR2","doi-asserted-by":"publisher","first-page":"C1","DOI":"10.1530\/ERC-16-0496","volume":"24","author":"SL Asa","year":"2017","unstructured":"Asa SL, Kucharczyk W, Ezzat S (2017) Pituitary acromegaly: not one disease. Endocr Relat Cancer 24:C1\u20134","journal-title":"Endocr Relat Cancer"},{"key":"2091_CR3","doi-asserted-by":"crossref","unstructured":"Akirov A, Asa SL, Amer L, Shimon I, Ezzat S (2019) The clinicopathological spectrum of acromegaly. J Clin Med. MDPI","DOI":"10.3389\/fendo.2019.00731"},{"key":"2091_CR4","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1186\/s12967-024-05736-0","volume":"22","author":"J Rymuza","year":"2024","unstructured":"Rymuza J, Kober P, Maksymowicz M, Nyc A, Mossakowska BJ, Woroniecka R et al (2024) High level of aneuploidy and recurrent loss of chromosome 11 as relevant features of somatotroph pituitary tumors. J Transl Med 22:994","journal-title":"J Transl Med"},{"key":"2091_CR5","doi-asserted-by":"crossref","unstructured":"Kober P, Rymuza J, Baluszek S, Maksymowicz M, Nyc A, Mossakowska BJ et al (2024) DNA methylation pattern in somatotroph pituitary neuroendocrine tumors. Neuroendocrinology 114:51\u201363","DOI":"10.1159\/000533692"},{"key":"2091_CR6","doi-asserted-by":"crossref","unstructured":"Dottermusch M, Ryba A, Ricklefs FL, Flitsch J, Schmid S, Glatzel M et al (2024) Pituitary neuroendocrine tumors with PIT1\/SF1 co-expression show distinct clinicopathological and molecular features. Acta Neuropathol 147","DOI":"10.1007\/s00401-024-02686-1"},{"key":"2091_CR7","doi-asserted-by":"crossref","unstructured":"Rymuza J, Kober P, Rusetska N, Mossakowska BJ, Maksymowicz M, Nyc A et al (2022) Transcriptomic classification of pituitary neuroendocrine tumors causing acromegaly. Cells 11:3846","DOI":"10.3390\/cells11233846"},{"key":"2091_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.humpath.2020.12.001","volume":"110","author":"S Silva-Ortega","year":"2021","unstructured":"Silva-Ortega S, Garc\u00eda-Martinez A, Niveiro de Jaime M, Torregrosa ME, Abarca J, Monjas I et al (2021) Proposal of a clinically relevant working classification of pituitary neuroendocrine tumors based on pituitary transcription factors. Hum Pathol 110:20\u201330","journal-title":"Hum Pathol"},{"key":"2091_CR9","doi-asserted-by":"crossref","unstructured":"Hong SW, Kim SH, Lim SH, Lee EJ, Kim SH, Ku CR et al (2021) Clinical relevance of new world health organization classification system for pituitary adenomas: a validation study with 2-Year experience. Front Oncol 11","DOI":"10.3389\/fonc.2021.739290"},{"key":"2091_CR10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s12022-018-9562-3","volume":"30","author":"KM Tordjman","year":"2019","unstructured":"Tordjman KM, Greenman Y, Ram Z, Hershkovitz D, Aizenstein O, Ariel O et al (2019) Plurihormonal pituitary tumor of Pit-1 and SF-1 lineages, with synchronous collision corticotroph tumor: a possible stem cell phenomenon. Endocr Pathol 30:74\u201380","journal-title":"Endocr Pathol"},{"key":"2091_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1293\/tox.26.209","volume":"26","author":"H Yasuno","year":"2013","unstructured":"Yasuno H, Watanabe T, Miyamoto Y, Kandori H, Yamasaki H, Fukuda R (2013) Expression of steroidogenic factor 1 and pituitary specific transcription factor 1 in rat pituitary adenomas. J Toxicol Pathol 26:209\u2013213","journal-title":"J Toxicol Pathol"},{"key":"2091_CR12","doi-asserted-by":"crossref","unstructured":"McDermott MT, Haugen BR, Gordon DF, Wood WM, Brown NS, Bauer CA (1999) Reverse transcription polymerase chain reaction analysis of pituitary hormone, Pit-1 and steroidogenic Factor-1 messenger RNA expression in pituitary tumors. Pituitary 2:217\u2013224.","DOI":"10.1023\/A:1009957411973"},{"key":"2091_CR13","doi-asserted-by":"crossref","unstructured":"Asa SL, Puy LA, Lew AM, Sundmark VC, Elsholtz HP (1993) Cell type-specific expression of the pituitary transcription activator pit-1 in the human pituitary and pituitary adenomas. J Clin Endocrinol Metab 77:1275\u20131280","DOI":"10.1210\/jcem.77.5.8077321"},{"key":"2091_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ccell.2019.11.002","volume":"37","author":"M Neou","year":"2020","unstructured":"Neou M, Villa C, Armignacco R, Jouinot A, Raffin-Sanson ML, Septier A et al (2020) Pangenomic classification of pituitary neuroendocrine tumors. Cancer Cell 37:123\u2013134e5","journal-title":"Cancer Cell"},{"key":"2091_CR15","doi-asserted-by":"crossref","unstructured":"Fookeerah P, Varikatt W, Shingde M, Dexter MAJ, McLean M (2023) Somatostatin receptor expression and clinical outcome of multilineage pituitary tumours expressing PIT1 and SF1. Endocr Connect 12","DOI":"10.1530\/EC-23-0328"},{"key":"2091_CR16","doi-asserted-by":"crossref","unstructured":"Asa SL, Mete O, Riddle ND, Perry A (2023) Multilineage pituitary neuroendocrine tumors (PitNETs) expressing PIT1 and SF1. Endocr Pathol 34","DOI":"10.1007\/s12022-023-09777-x"},{"key":"2091_CR17","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1097\/PAS.0000000000002306","volume":"48","author":"BK Kleinschmidt-DeMasters","year":"2024","unstructured":"Kleinschmidt-DeMasters BK (2024) Reassessment of plurihormonal pituitary adenomas\/pitnets. Am J Surg Pathol 48:1600\u20131616","journal-title":"Am J Surg Pathol"},{"key":"2091_CR18","doi-asserted-by":"crossref","unstructured":"Zhang F, Zhang Q, Zhu J, Yao B, Ma C, Qiao N et al (2022) Integrated proteogenomic characterization across major histological types of pituitary neuroendocrine tumors. Cell Res 32","DOI":"10.1038\/s41422-022-00736-5"},{"key":"2091_CR19","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/s42003-022-04272-1","volume":"5","author":"A Yamato","year":"2022","unstructured":"Yamato A, Nagano H, Gao Y, Matsuda T, Hashimoto N, Nakayama A et al (2022) Proteogenomic landscape and clinical characterization of GH-producing pituitary adenomas\/somatotroph pituitary neuroendocrine tumors. Commun Biol 5:1304","journal-title":"Commun Biol"},{"key":"2091_CR20","doi-asserted-by":"crossref","unstructured":"da Silva-J\u00fanior RMP, Bueno AC, Martins CS, Coelli-Lacchini F, Okanobo Ozaki JG, de Almeida E, Silva DC et al (2022) Integrating methylome and transcriptome signatures expands the molecular classification of the pituitary tumors. J Clin Endocrinol Metab. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/36504388","DOI":"10.1210\/clinem\/dgac703"},{"key":"2091_CR21","doi-asserted-by":"crossref","unstructured":"Patro R, Duggal G, Love MI, Irizarry RA, Kingsford C (2017) Salmon provides fast and bias-aware quantification of transcript expression. Nat Methods 14","DOI":"10.1038\/nmeth.4197"},{"key":"2091_CR22","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.12688\/f1000research.7563.1","volume":"4","author":"C Soneson","year":"2015","unstructured":"Soneson C, Love MI, Robinson MD (2015) Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. F1000Res 4:1521","journal-title":"F1000Res"},{"key":"2091_CR23","doi-asserted-by":"crossref","unstructured":"Liao Y, Smyth GK, Shi W, FeatureCounts (2014) An efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30","DOI":"10.1093\/bioinformatics\/btt656"},{"key":"2091_CR24","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:550","journal-title":"Genome Biol"},{"key":"2091_CR25","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W et al (2015) Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43:e47\u2013e47","journal-title":"Nucleic Acids Res"},{"key":"2091_CR26","doi-asserted-by":"crossref","unstructured":"Langfelder P, Horvath S (2008) WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9","DOI":"10.1186\/1471-2105-9-559"},{"key":"2091_CR27","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1038\/ncomms3464","volume":"4","author":"MNC Fletcher","year":"2013","unstructured":"Fletcher MNC, Castro MAA, Wang X, de Santiago I, O\u2019Reilly M, Chin S-F et al (2013) Master regulators of FGFR2 signalling and breast cancer risk. Nat Commun 4:2464","journal-title":"Nat Commun"},{"key":"2091_CR28","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/carcin\/bgw065","volume":"37","author":"TM Campbell","year":"2016","unstructured":"Campbell TM, Castro MAA, de Santiago I, Fletcher MNC, Halim S, Prathalingam R et al (2016) FGFR2 risk SNPs confer breast cancer risk by augmenting oestrogen responsiveness. Carcinogenesis 37:741\u2013750","journal-title":"Carcinogenesis"},{"key":"2091_CR29","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/ng.3458","volume":"48","author":"MAA Castro","year":"2016","unstructured":"Castro MAA, de Santiago I, Campbell TM, Vaughn C, Hickey TE, Ross E et al (2016) Regulators of genetic risk of breast cancer identified by integrative network analysis. Nat Genet 48:12\u201321","journal-title":"Nat Genet"},{"key":"2091_CR30","doi-asserted-by":"crossref","unstructured":"Zhang Q, Yao B, Long X, Chen Z, He M, Wu Y et al (2023) Single-cell sequencing identifies differentiation-related markers for molecular classification and recurrence prediction of PitNET. Cell Rep Med 4","DOI":"10.1016\/j.xcrm.2023.100934"},{"key":"2091_CR31","doi-asserted-by":"crossref","unstructured":"Asuzu DT, Alvarez R, Fletcher PA, Mandal D, Johnson K, Wu W et al (2022) Pituitary adenomas evade apoptosis via Noxa deregulation in cushing\u2019s disease. Cell Rep 40","DOI":"10.1016\/j.celrep.2022.111223"},{"key":"2091_CR32","doi-asserted-by":"crossref","unstructured":"Lyu L, Jiang Y, Ma W, Li H, Liu X, Li L et al (2023) Single-cell sequencing of PIT1-positive pituitary adenoma highlights the pro-tumour microenvironment mediated by IFN-\u03b3-induced tumour-associated fibroblasts remodelling. Br J Cancer 128","DOI":"10.1038\/s41416-022-02126-5"},{"key":"2091_CR33","doi-asserted-by":"crossref","unstructured":"Yan N, Xie W, Wang D, Fang Q, Guo J, Chen Y et al (2024) Single-cell transcriptomic analysis reveals tumor cell heterogeneity and immune microenvironment features of pituitary neuroendocrine tumors. Genome Med 16","DOI":"10.1186\/s13073-023-01267-3"},{"key":"2091_CR34","doi-asserted-by":"crossref","unstructured":"Zhang Y, Wang L, Yi X, Ma X, Wu H, Zhang M et al (2024) Single-cell and spatial transcriptomic analyses reveal heterogeneity characteristics and specific cell subtype regulators in growth hormone-secreting pituitary adenomas. Int J Surg. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/39784532","DOI":"10.1097\/JS9.0000000000002178"},{"key":"2091_CR35","doi-asserted-by":"publisher","first-page":"5275","DOI":"10.1038\/s41467-020-19012-4","volume":"11","author":"S Zhang","year":"2020","unstructured":"Zhang S, Cui Y, Ma X, Yong J, Yan L, Yang M et al (2020) Single-cell transcriptomics identifies divergent developmental lineage trajectories during human pituitary development. Nat Commun 11:5275","journal-title":"Nat Commun"},{"key":"2091_CR36","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41592-022-01408-3","volume":"19","author":"D He","year":"2022","unstructured":"He D, Zakeri M, Sarkar H, Soneson C, Srivastava A, Patro R (2022) Alevin-fry unlocks rapid, accurate and memory-frugal quantification of single-cell RNA-seq data. Nat Methods 19:316\u2013322","journal-title":"Nat Methods"},{"key":"2091_CR37","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao Y, Stuart T, Kowalski MH, Choudhary S, Hoffman P, Hartman A et al (2024) Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat Biotechnol 42:293\u2013304","journal-title":"Nat Biotechnol"},{"key":"2091_CR38","doi-asserted-by":"crossref","unstructured":"Germain PL, Robinson MD, Lun A, Garcia Meixide C, Macnair W (2022) Doublet identification in single-cell sequencing data using ScDblFinder. F1000Res 10","DOI":"10.12688\/f1000research.73600.2"},{"key":"2091_CR39","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler A, Hoffman P, Smibert P, Papalexi E, Satija R (2018) Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol 36:411\u2013420","journal-title":"Nat Biotechnol"},{"key":"2091_CR40","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K et al (2019) Fast, sensitive and accurate integration of single-cell data with harmony. Nat Methods 16:1289\u20131296","journal-title":"Nat Methods"},{"key":"2091_CR41","doi-asserted-by":"crossref","unstructured":"Street K, Risso D, Fletcher RB, Das D, Ngai J, Yosef N et al (2018) Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics. BMC Genomics 19","DOI":"10.1186\/s12864-018-4772-0"},{"key":"2091_CR42","doi-asserted-by":"crossref","unstructured":"Van den Berge K, Roux de B\u00e9zieux H, Street K, Saelens W, Cannoodt R, Saeys Y et al (2020) Trajectory-based differential expression analysis for single-cell sequencing data. Nat Commun 11","DOI":"10.1038\/s41467-020-14766-3"},{"key":"2091_CR43","doi-asserted-by":"crossref","unstructured":"Cao J, Spielmann M, Qiu X, Huang X, Ibrahim DM, Hill AJ et al (2019) The single-cell transcriptional landscape of mammalian organogenesis. Nature 566","DOI":"10.1038\/s41586-019-0969-x"},{"key":"2091_CR44","doi-asserted-by":"crossref","unstructured":"Badia-I-Mompel P, V\u00e9lez Santiago J, Braunger J, Geiss C, Dimitrov D, M\u00fcller-Dott S et al (2022) DecoupleR: ensemble of computational methods to infer biological activities from omics data. Bioinf Adv 2","DOI":"10.1093\/bioadv\/vbac016"},{"key":"2091_CR45","doi-asserted-by":"crossref","unstructured":"Muzellec B, Tele\u0144czuk M, Cabeli V, Andreux M (2023) PyDESeq2: a python package for bulk RNA-seq differential expression analysis. Bioinformatics 39","DOI":"10.1093\/bioinformatics\/btad547"},{"key":"2091_CR46","doi-asserted-by":"crossref","unstructured":"Kanehisa M, Goto S (2000) KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28:27\u201330","DOI":"10.1093\/nar\/28.1.27"},{"key":"2091_CR47","doi-asserted-by":"crossref","unstructured":"Morabito S, Reese F, Rahimzadeh N, Miyoshi E, Swarup V (2023) HdWGCNA identifies co-expression networks in high-dimensional transcriptomics data. Cell Rep Methods 3","DOI":"10.1016\/j.crmeth.2023.100498"},{"key":"2091_CR48","doi-asserted-by":"crossref","unstructured":"Gao R, Bai S, Henderson YC, Lin Y, Schalck A, Yan Y et al (2021) Delineating copy number and clonal substructure in human tumors from single-cell transcriptomes. Nat Biotechnol 39","DOI":"10.1038\/s41587-020-00795-2"},{"key":"2091_CR49","doi-asserted-by":"crossref","unstructured":"Do\u011fukan FM, Karatay H, Y\u00fczkan S, Burhan \u015e, Erkan B, Y\u0131lmaz-\u00d6zg\u00fcven B (2024) Clinicopathological correlates of PIT1 and SF1-Multilineage pituitary neuroendocrine tumors and the diagnostic utility of NKX2.2 immunohistochemistry in pituitary pathology. Arch Pathol Lab Med 149:83\u201389","DOI":"10.5858\/arpa.2023-0543-OA"},{"key":"2091_CR50","doi-asserted-by":"crossref","unstructured":"Asa SL, Mete O, Perry A, Osamura RY (2022) Overview of the 2022 WHO classification of pituitary tumors. Endocr Pathol. Springer, pp 6\u201326","DOI":"10.1007\/s12022-022-09703-7"},{"key":"2091_CR51","doi-asserted-by":"crossref","unstructured":"Wang X, Tang H, Bie Z, Wang Y, Yuan R, Zhang Z et al (2024) Clinical and pathological features of Pit1\/SF1 multilineage pituitary neuroendocrine tumor. Neurosurgery 95","DOI":"10.1227\/neu.0000000000002846"},{"key":"2091_CR52","doi-asserted-by":"crossref","unstructured":"Faraj CA, McCutcheon IE, Gubbiotti MA (2025) PIT-1\/SF-1 co-expression in pituitary neuroendocrine tumors (PitNETs) with comprehensive review of the literature: how should we best characterize these neoplasms? Ann Diagn Pathol 74","DOI":"10.1016\/j.anndiagpath.2024.152398"},{"key":"2091_CR53","doi-asserted-by":"crossref","unstructured":"Mihajlovi\u0107 M, Peki\u0107 S, Dokni\u0107 M, Stojanovi\u0107 M, Ra\u0161i\u0107 D, Milji\u0107 D et al (2024) Plurihormonal pituitary neuroendocrine Tumours \u2013 A single centre experience. Int J Surg Pathol 32","DOI":"10.1177\/10668969231183712"},{"key":"2091_CR54","doi-asserted-by":"crossref","unstructured":"Ellsworth BS, Stallings CE (2018) Molecular mechanisms governing embryonic differentiation of pituitary somatotropes. Trends in Endocrinology and Metabolism","DOI":"10.1016\/j.tem.2018.04.009"},{"key":"2091_CR55","doi-asserted-by":"crossref","unstructured":"Le Cicl\u00e9 C, Cohen-Tannoudji J, L\u2019H\u00f4te D (2024) Recent advances in the Understanding of gonadotrope lineage differentiation in the developing pituitary. Neuroendocrinology. S. Karger AG","DOI":"10.1159\/000542513"},{"key":"2091_CR56","doi-asserted-by":"crossref","unstructured":"Ngan ESW, Cheng PKW, Leung PCK, Chow BKC (1999) Steroidogenic factor-1 interacts with a gonadotrope-specific element within the first exon of the human gonadotropin-releasing hormone receptor gene to mediate gonadotrope-specific expression. Endocrinology 140","DOI":"10.1210\/en.140.6.2452"},{"key":"2091_CR57","doi-asserted-by":"crossref","unstructured":"Fowkes RC, Burrin JM (2003) Steroidogenic factor-1: a key regulator of gonadotroph gene expression. J Endocrinol 177","DOI":"10.1677\/joe.0.1770345"},{"key":"2091_CR58","doi-asserted-by":"crossref","unstructured":"Mitsui Y, Mukai K, Otsuki M, Oshino S, Saitoh Y, Kohara M et al (2024) Growth hormone increase by luteinizing hormone-releasing hormone reflects gonadotroph-related characteristics in acromegaly. Pituitary 27:527\u2013536","DOI":"10.1007\/s11102-024-01410-2"},{"key":"2091_CR59","doi-asserted-by":"crossref","unstructured":"Hage M, Janot C, Salenave S, Chanson P, Kamenick\u00fd P (2021) Etiology and outcome of acromegaly in patients with a paradoxical GH response to glucose. Eur J Endocrinol. BioScientifica Ltd.; pp. R261\u20138","DOI":"10.1530\/EJE-20-1448"},{"key":"2091_CR60","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1210\/jc.2018-01504","volume":"104","author":"M Hage","year":"2019","unstructured":"Hage M, Chalign\u00e9 R, Viengchareun S, Villa C, Salenave S, Bouligand J et al (2019) Hypermethylator phenotype and ectopic GIP receptor in GNAS mutation-negative somatotropinomas. J Clin Endocrinol Metab 104:1777\u20131787","journal-title":"J Clin Endocrinol Metab"},{"key":"2091_CR61","doi-asserted-by":"crossref","unstructured":"Hanley NA, Ikeda Y, Luo X, Parker KL (2000) Steroidogenic factor 1 (SF-1) is essential for ovarian development and function. Mol Cell Endocrinol 163","DOI":"10.1016\/S0303-7207(99)00237-3"},{"key":"2091_CR62","doi-asserted-by":"crossref","unstructured":"Chiloiro S, Giampietro A, Gessi M, Lauretti L, Mattogno PP, Cerroni L et al (2023) CD68\u2009+\u2009and CD8\u2009+\u2009immune cells are associated with the growth pattern of somatotroph tumors and response to first generation somatostatin analogs. J Neuroendocrinol 35","DOI":"10.1111\/jne.13263"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02091-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-025-02091-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02091-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T22:31:19Z","timestamp":1757457079000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-025-02091-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2091"],"URL":"https:\/\/doi.org\/10.1186\/s40478-025-02091-z","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,14]]},"assertion":[{"value":"7 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable; secondary use of data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"174"}}